Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion type Assertion NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_head.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion description "[As circulating chromogranin-A (CgA) levels are found to correlate with tumor progression and the status of hormone refractoriness, our current study attempted to assess whether CgA-positive cells would be preferentially distributed in epithelial structures with FBCLD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion evidence source_evidence_literature NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion SIO_000772 21980038 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion wasDerivedFrom befree-20150227 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.
- NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_assertion wasGeneratedBy ECO_0000203 NP313175.RAN2cS_DlUpdzBz7U8BPwEgcVgaPIKr46-OqXrEdn-OyE130_provenance.